Sign inJoin waitlistJoin the waitlist

Brad Pasternak

Medical Director, Inflammatory Bowel Disease Clinic · University of Arizona College of Medicine - Phoenix

Credentials: · · ·

History

Inflammatory Bowel Disease Clinic · University of Arizona College of Medicine - Phoenix
Present
Pediatric Fecal Microbiota Transplant Program · University of Arizona College of Medicine - Phoenix
Present
University of Arizona College of Medicine - Phoenix
Present

Pediatric Gastroenterology
Cincinnati Children's Hospital Medical Center
2008–2011
Pediatric Gastroenterology
University of Chicago Medical Center
2005–2008
Pediatrics
SUNY Downstate Health Sciences University
2002–2005
SACKLER SCH OF MED, TEL AVIV UNIV, RAMAT AVIV, ISRAEL
1998–2002

Research

Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement
Review · Journal of Pediatric Gastroenterology and Nutrition · 2013 · 98 citations
Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis
Inflammatory Bowel Diseases · 2010 · First of 14 authors · 76 citations
Regulation of intestinal barrier function by signal transducer and activator of transcription 5b
Gut · 2009 · 48 citations

Jeremy Adler
7 papers
Ashish Patel
6 papers
Jonathan Moses
6 papers
Sabina Ali
5 papers
Lisa McMahon
4 papers
David Suskind
3 papers
Edwin de Zoeten
3 papers
Elizabeth Hilow
3 papers
Erica Chang
3 papers · 3 as a resident
Jennifer Dotson
3 papers
Perseus Patel
3 papers · 2 as a fellow
Archana Anandakrishnan
2 papers · 2 as a fellow

Clinical trials

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Site PI · Recruiting · Phase 3
Takeda
2025–2030
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Site PI · Recruiting · Phase 3
Takeda
2025–2028